Impact of mycoplasma pneumonia infection on urticaria: A nationwide, population-based retrospective cohort study in Taiwan


Autoři: Su-Boon Yong aff001;  Wei-Chu Yeh aff004;  Hsing-Ju Wu aff005;  Huang-Hsi Chen aff001;  Jing-Yang Huang aff007;  Tung-Ming Chang aff008;  James Cheng-Chung Wei aff001
Působiště autorů: Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan aff001;  Division of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, Show Chwan Memorial Hospital, Changhua, Taiwan aff002;  Department of Nursing, Meiho University, Pingtung, Taiwan aff003;  Department of Emergency, Show Chwan Memorial Hospital, Changhua, Taiwan aff004;  Research Assistant Center, Show Chwan Memorial Hospital, Changhua, Taiwan aff005;  Department of Medical Research, Chang Bing Show Chwan Memorial Hospital, Lukang Town, Changhua County, Taiwan aff006;  Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan aff007;  Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan aff008;  Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan aff009;  Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan aff010
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
doi: 10.1371/journal.pone.0226759

Souhrn

Mycoplasma pneumonia (MP) infection might be pathogenically closely related to urticaria. This study is a nationwide population-based cohort study from 1997 to 2013, which investigated the association between MP infection and urticaria in Taiwan. A total of 1,175 patients were included for the study group, and 2,350 for the control group. Multivariate Cox regression analysis was performed to estimate the adjusted hazard ratio (aHR) for urticaria. Result showed that 254 patients with new-onset urticaria were involved in the study group and 465 incident cases in the control group. The incidence rates (per 100,000 person-months) of urticaria were 37.2 and 32.5 in the study and control groups, respectively. The relative risk is 1.1 (95% CI = 1.0–1.3) indicating no significant correlation between MP and urticaria. The multivariate analysis revealed that the risk of urticaria with MP infection (aHR = 1.1, P = 0.1058) had no statistically significance difference compared to the control group. However, the risk of urticaria in MP-infected patients aged between 20 and 59 years old was found to have increased (aHR = 1.6, 95% CI = 1.1–2.2) prior to a diagnosis.

Klíčová slova:

Diagnostic medicine – Pediatric infections – Respiratory infections – Streptococcal infections – Upper respiratory tract infections – Urticaria – Mycoplasma pneumonia – Mycoplasma pneumoniae


Zdroje

1. Jover F, Cuadrado JM, Ivars J, Merino J. [Urticarial vasculitis and infection due to Mycoplasma pneumoniae]. Enfermedades infecciosas y microbiologia clinica. 2003;21(4):218–9. 12681140

2. Honda T, Nomura T, Kabashima K. Advances in atopic dermatitis and urticarial in 2016. The Journal of allergy and clinical immunology. 2017;140(2):369–76. doi: 10.1016/j.jaci.2017.06.005 28652155

3. Sanjuan MA, Sagar D, Kolbeck R. Role of IgE in autoimmunity. J Allergy Clin Immunol. 2016;137(6):1651–61. doi: 10.1016/j.jaci.2016.04.007 27264000

4. Novembre E, Cianferoni A, Mori F, Barni S, Calogero C, Bernardini R, et al. Urticaria and urticaria related skin condition/disease in children. Eur Ann Allergy Clin Immunol. 2008;40(1):5–13. 18700329

5. Moolani Y, Lynde C, Sussman G. Advances in Understanding and Managing Chronic Urticaria. F1000Research. 2016;5:F1000 Faculty Rev-177.

6. Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF. Pathophysiology of urticaria. Clinical reviews in allergy & immunology. 2006;30(1):3–11.

7. Radonjic-Hoesli S, Hofmeier KS, Micaletto S, Schmid-Grendelmeier P, Bircher A, Simon D. Urticaria and Angioedema: an Update on Classification and Pathogenesis. Clin Rev Allergy Immunol. 2018;54(1):88–101. doi: 10.1007/s12016-017-8628-1 28748365

8. Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol. 2004;4(5):387–96. doi: 10.1097/00130832-200410000-00010 15349038

9. Minciullo PL, Cascio A, Barberi G, Gangemi S. Urticaria and bacterial infections. Allergy Asthma Proc. 2014;35(4):295–302. doi: 10.2500/aap.2014.35.3764 24857191

10. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy, asthma, and clinical immunology: official journal of the Canadian Society of Allergy and Clinical Immunology. 2009;5(1):10-.

11. Shin M, Lee S. Prevalence and Causes of Childhood Urticaria. Allergy, asthma & immunology research. 2017;9(3):189–90.

12. Liu TH, Lin YR, Yang KC, Chou CC, Chang YJ, Wu HP. First attack of acute urticaria in pediatric emergency department. Pediatr Neonatol. 2008;49(3):58–64. doi: 10.1016/S1875-9572(08)60014-5 18947000

13. Sackesen C, Sekerel BE, Orhan F, Kocabas CN, Tuncer A, Adalioglu G. The etiology of different forms of urticaria in childhood. Pediatric dermatology. 2004;21(2):102–8. doi: 10.1111/j.0736-8046.2004.21202.x 15078346

14. Kano Y, Mitsuyama Y, Hirahara K, Shiohara T. Mycoplasma pneumoniae infection-induced erythema nodosum, anaphylactoid purpura, and acute urticaria in 3 people in a single family. J Am Acad Dermatol. 2007;57(2 Suppl):S33–5. doi: 10.1016/j.jaad.2005.08.027 17637367

15. Shah KN, Honig PJ, Yan AC. "Urticaria multiforme": a case series and review of acute annular urticarial hypersensitivity syndromes in children. Pediatrics. 2007;119(5):e1177–83. doi: 10.1542/peds.2006-1553 17470565

16. Timitilli A, Di Rocco M, Nattero G, Tacchella A, Giacchino R. Unusual manifestations of infections due to Mycoplasma pneumoniae in children. Infez Med. 2004;12(2):113–7. 15316297

17. Wu CC, Kuo HC, Yu HR, Wang L, Yang KD. Association of acute urticaria with Mycoplasma pneumoniae infection in hospitalized children. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2009;103(2):134–9.

18. Poddighe D, Comi EV, Brambilla I, Licari A, Bruni P, Marseglia GL. Increased Total Serum Immunoglobulin E in Children Developing Mycoplasma pneumoniae-related Extra-pulmonary Diseases. Iran J Allergy Asthma Immunol. 2018;17(5):490–6. 30518191

19. Lim C, Lim S, Lim K. Mycoplasma pneumoniae infection in adults with acute and chronic urticaria. Cutis. 2015;95(5):E13–4. 26057513

20. Hung YN, Kadziola Z, Brnabic AJ, Yeh JF, Fuh JL, Hwang JP, et al. The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database. Clinicoecon Outcomes Res. 2016;8:387–95. doi: 10.2147/CEOR.S93323 27536149

21. Chen CM, Chen HJ, Chen WS, Lin CC, Hsu CC, Hsu YH. Clinical effectiveness of influenza vaccination in patients with rheumatoid arthritis. Int J Rheum Dis. 2018;21(6):1246–53. doi: 10.1111/1756-185X.13322 29879317

22. Chu KA, Chen W, Hsu CY, Hung YM, Wei JC. Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan. PLoS One. 2019;14(1):e0210750. doi: 10.1371/journal.pone.0210750 30640923

23. Tomkinson JG. ÆTIOLOGY OF URTICARIA*. British Journal of Dermatology. 1926;38(11):431–43.

24. Barber HW. CHRONIC URTICARIA AND ANGEIO—NEUROTIC ŒDEMA DUE TO BACTERIAL SENSITISATION. British Journal of Dermatology. 1923;35(6):209–18.

25. Dua J, Nandagudi A, Sutcliffe N. Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still’s disease. Rheumatology international. 2012;32(12):4053–6. doi: 10.1007/s00296-011-2107-4 21918897

26. Abe R. Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis. The Journal of dermatology. 2015;42(1):42–8. doi: 10.1111/1346-8138.12674 25355273

27. Kaplan AP. Chronic urticaria: pathogenesis and treatment. The Journal of allergy and clinical immunology. 2004;114(3):465–74; quiz 75. doi: 10.1016/j.jaci.2004.02.049 15356542


Článek vyšel v časopise

PLOS One


2019 Číslo 12